Heikki Jouttijärvi
Corporate Officer/Principal bij ADVERUM BIOTECHNOLOGIES, INC.
Profiel
Heikki Jouttijärvi currently works at Adverum Biotechnologies, Inc., as Senior VP-Manufacturing & Supply Chain Management from 2023.
Mr. Jouttijärvi also formerly worked at Menlo Therapeutics, Inc., as Vice President-Technical Operations and Santen Pharmaceutical Co., Ltd., as VP, Head-Global External Manufacturing & Sourcing from 1999 to 2015.
Mr. Jouttijärvi received his graduate degree from the University of Helsinki.
Actieve functies van Heikki Jouttijärvi
| Bedrijven | Functie | Begin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 25-06-2020 |
Eerdere bekende functies van Heikki Jouttijärvi
| Bedrijven | Functie | Einde |
|---|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | 01-01-2015 |
| VYNE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Opleiding van Heikki Jouttijärvi
| University of Helsinki | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
